Michael Ward
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
Papers in
-
- Pharmacogenetics and Drug Metabolism 7
-
- Pharmaceutical Practices and Patient Outcomes 3
- Co-authors
- Ross A. McKinnonMichael J. SorichJohn D. HorowitzAgnès VitryElizabeth E. RougheadMatthew J. SykesSvetla GadzhanovaGillian E. Caughey
- Journals
- Journal of Pharmacy Practice and Research (5 papers)Drug Safety (4 papers)Multiple Sclerosis and Related Disorders (1 paper)Journal of Pharmaceutical Sciences (1 paper)Journal of Telemedicine and Telecare (1 paper)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Michael Ward
47 papers receiving 422 citations
Peers
Comparison fields: 5 of 97
- Pharmacology 80
- Geriatrics and Gerontology 23
- Cardiology and Cardiovascular Medicine 107
- Internal Medicine 13
- Rheumatology 49
Countries citing papers authored by Michael Ward
This map shows the geographic impact of Michael Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ward more than expected).
Fields of papers citing papers by Michael Ward
This network shows the impact of papers produced by Michael Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ward. The network helps show where Michael Ward may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Ward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 16 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 2 | |
| 11 | ABC television and the development of televised cricket | 2018 | 1 |
| 12 | 2016 | 10 | |
| 13 | 2016 | 5 | |
| 14 | 2015 | 4 | |
| 15 | 2013 | 8 | |
| 16 | 2010 | 2 | |
| 17 | 2010 | 5 | |
| 18 | 2010 | 76 | |
| 19 | Folic acid supplements to prevent neural tube defects: trends in East of Ireland 1996-2002. | 2004 | 33 |
| 20 | 2003 | 1 |
About Michael Ward
Michael Ward is a scholar working on Pharmacology, Geriatrics and Gerontology, Family Practice, Health Information Management and Pharmacology, having authored 50 papers that have together received 436 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Biosimilars and Bioanalytical Methods (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Acute Ischemic Stroke Management (3 papers). The work is most often cited by research in Pharmacology (80 citations), Geriatrics and Gerontology (23 citations), Cardiology and Cardiovascular Medicine (107 citations), Internal Medicine (13 citations) and Rheumatology (49 citations). Michael Ward has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Ross A. McKinnon, Michael J. Sorich, John D. Horowitz, Agnès Vitry, Elizabeth E. Roughead, Matthew J. Sykes, Svetla Gadzhanova, Gillian E. Caughey, Stephanie E. Reuter and Nicole Pratt. Their work appears in journals such as Journal of Pharmacy Practice and Research, Drug Safety, Multiple Sclerosis and Related Disorders, Journal of Pharmaceutical Sciences and Journal of Telemedicine and Telecare.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.